We are delighted to share some highly viewed papers on clinical research of cancer that were published in Cancers (ISSN: 2072-6694) in 2023. In addition, some Special Issues on this topic are open for submission. The following is a list of relevant papers and Special Issues that we believe will interest you:

“Current Main Topics in Multiple Myeloma”
by Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Attilio Olivieri and Massimo Offidani
Cancers 2023, 15(8), 2203; https://doi.org/10.3390/cancers15082203
Available online: https://www.mdpi.com/2072-6694/15/8/2203

“Management of Advanced Prostate Cancer in the Precision Oncology Era”
by Claire M. Gillette, Gabriel A. Yette, Scott D. Cramer and Laura S. Graham
Cancers 2023, 15(9), 2552; https://doi.org/10.3390/cancers15092552
Available online: https://www.mdpi.com/2072-6694/15/9/2552

“Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors”
by Vladimir Chernov, Anastasiya Rybina, Roman Zelchan, Anna Medvedeva, Olga Bragina, Nadejda Lushnikova, Artem Doroshenko, Evgeniy Usynin, Liubov Tashireva, Sergey Vtorushin et al.
Cancers 2023, 15(6), 1631; https://doi.org/10.3390/cancers15061631
Available online: https://www.mdpi.com/2072-6694/15/6/1631

“Development of a Patient Decision Aid for Rectal Cancer Patients with Clinical Complete Response after Neo-Adjuvant Treatment”
by Lien Smets, Annelies Debucquoy, Eva Oldenburger, Chantal Van Audenhove, Lynn Debrun, Jeroen Dekervel, Gabriele Bislenghi, André D’Hoore, Albert Wolthuis and Karin Haustermans
Cancers 2023, 15(3), 806; https://doi.org/10.3390/cancers15030806
Available online: https://www.mdpi.com/2072-6694/15/3/806

“A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma”
by Nam Bui, Hilary Dietz, Sheima Farag, Angela C. Hirbe, Michael J. Wagner, Brian A. Van Tine, Kristen Ganjoo, Robin L. Jones, Vicki L. Keedy and Elizabeth J. Davis
Cancers 2023, 15(9), 2617; https://doi.org/10.3390/cancers15092617
Available online: https://www.mdpi.com/2072-6694/15/9/2617

“Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer”
by Rieneke T. Lugtenberg, Stefanie de Groot, Danny Houtsma, Vincent O. Dezentjé, Annelie J. E. Vulink, Maarten J. Fischer, Johanneke E. A. Portielje, Jacobus J. M. van der Hoeven, Hans Gelderblom, Hanno Pijl et al.
Cancers 2023, 15(6), 1691; https://doi.org/10.3390/cancers15061691
Available online: https://www.mdpi.com/2072-6694/15/6/1691

“Bone and Soft Tissue Tumors: Molecular Mechanisms, Clinical Practice, and Emerging Therapeutics” Edited by Prof. Dr. Toshihiro Akisue, Dr. Shintaro Iwata and Dr. Toru Akiyama Submission deadline: 31 May 2024	“The Evolving Treatment and Clinical Trials of Hepatocellular Carcinoma” Edited by Dr. Zachary J. Brown and Dr. John D. Allendorf Submission deadline: 31 May 2024
“Clinical Outcomes in Urologic Cancers” Edited by Dr. Simone Morra and Prof. Dr. Pierre Karakiewicz Submission deadline: 30 June 2024	“Prognostic Factors in Urologic Cancers—Assessment and Integration into Clinical Care“ Edited by Prof. Dr. Maximilian Burger and Prof. Dr. Christian Thomas Submission deadline: 30 June 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office